Xenogenics Received Rights to Polyanhydride Compounds Drug Delivery Patent
2/16/2012 9:59:47 AM
More...
|
Xenogenics Retains the Emmes Group to Advise on Fund Raising Efforts
2/23/2011 8:48:19 AM
More...
|
MultiCell Technologies Inc. (MCET.OB)'s Majority Owned Subsidiary Xenogenics Acquires Bioabsorbable Interventional Cardiology Stent Assets from Western Technology Investment and Silicon Valley Bank
10/20/2010 7:38:23 AM
More...
|
MultiCell Technologies Inc.'s (MUCL) Xenogenics Subsidiary Granted Artificial Liver Device Patent; Sybiol Device Offers Potential To Treat Millions Of Patients With Liver Trauma Or Insufficiency
10/19/2005 5:12:49 PM
More...
|
Exten Industries' (EXTI) Xenogenics Subsidiary Gets Notice Of Liver Device Patent
10/19/2005 5:10:22 PM
More...
|
Exten Industries' (EXTI) Subsidiary MultiCell Technologies Inc. (EXTI) Captures Stem Cell License
10/19/2005 5:09:31 PM
More...
|